BACKGROUND: We investigated the influence of chronic smoking on ocular vascular reactivity during breathing of 100% oxygen. METHODS: Retinal vascular reactivity was tested during inhalation of 100% oxygen over 10 min. The observer-masked two-cohort study was performed in 24 healthy male volunteers (12 smokers and 12 nonsmokers) using the Zeiss Retinal Vessel Analyzer and laser Doppler velocimetry. From these parameters retinal blood flow was calculated. RESULTS: Hyperoxia significantly decreased arterial (smokers: p<0.001 vs baseline; nonsmokers: p=0.003 vs baseline) and venous (smokers: p<0.001 vs baseline; nonsmokers: p<0.001 vs baseline) diameters. This decrease was significantly more pronounced in smokers (arterial diameter: p<0.001, venous diameter: p=0.003). Hyperoxia decreased venous blood flow velocity (smokers: p=0.02 vs baseline; nonsmokers: p<0.001 vs baseline) to a comparable degree (p=0.51). The two groups showed a comparable decrease in retinal blood flow during hyperoxia (smokers: p<0.001 vs baseline; nonsmokers: p<0.001 vs baseline; p=0.76 between groups). The decrease of PCO(2) during inhalation of 100% oxygen was significantly more pronounced in smokers than in nonsmokers (p=0.038). CONCLUSION: The present study indicates an abnormal retinal vascular response to hyperoxia in smokers. Further studies are needed to identify possible neural or humoral factors involved in this shifted vasoconstrictory status in smokers.
BACKGROUND: We investigated the influence of chronic smoking on ocular vascular reactivity during breathing of 100% oxygen. METHODS: Retinal vascular reactivity was tested during inhalation of 100% oxygen over 10 min. The observer-masked two-cohort study was performed in 24 healthy male volunteers (12 smokers and 12 nonsmokers) using the Zeiss Retinal Vessel Analyzer and laser Doppler velocimetry. From these parameters retinal blood flow was calculated. RESULTS:Hyperoxia significantly decreased arterial (smokers: p<0.001 vs baseline; nonsmokers: p=0.003 vs baseline) and venous (smokers: p<0.001 vs baseline; nonsmokers: p<0.001 vs baseline) diameters. This decrease was significantly more pronounced in smokers (arterial diameter: p<0.001, venous diameter: p=0.003). Hyperoxia decreased venous blood flow velocity (smokers: p=0.02 vs baseline; nonsmokers: p<0.001 vs baseline) to a comparable degree (p=0.51). The two groups showed a comparable decrease in retinal blood flow during hyperoxia (smokers: p<0.001 vs baseline; nonsmokers: p<0.001 vs baseline; p=0.76 between groups). The decrease of PCO(2) during inhalation of 100% oxygen was significantly more pronounced in smokers than in nonsmokers (p=0.038). CONCLUSION: The present study indicates an abnormal retinal vascular response to hyperoxia in smokers. Further studies are needed to identify possible neural or humoral factors involved in this shifted vasoconstrictory status in smokers.
Authors: K Polak; G Dorner; B Kiss; E Polska; O Findl; G Rainer; H G Eichler; L Schmetterer Journal: Br J Ophthalmol Date: 2000-11 Impact factor: 4.638
Authors: K Gugleta; A Kochkorov; N Waldmann; A Polunina; R Katamay; J Flammer; S Orgul Journal: Graefes Arch Clin Exp Ophthalmol Date: 2011-10-19 Impact factor: 3.117
Authors: Jennifer E Thorne; Ebenezer Daniel; Douglas A Jabs; Sanjay R Kedhar; George B Peters; James P Dunn Journal: Am J Ophthalmol Date: 2008-03-05 Impact factor: 5.258
Authors: Mary E Lott; Julia E Slocomb; Zhaohui Gao; Robert A Gabbay; David Quillen; Thomas W Gardner; Kerstin Bettermann Journal: Microvasc Res Date: 2015-05-20 Impact factor: 3.514
Authors: K Gugleta; N Waldmann; A Polunina; A Kochkorov; R Katamay; J Flammer; S Orgul Journal: Graefes Arch Clin Exp Ophthalmol Date: 2013-02-19 Impact factor: 3.117
Authors: Gerald Liew; A Richey Sharrett; Jie Jin Wang; Ronald Klein; Barbara E K Klein; Paul Mitchell; Tien Y Wong Journal: Arch Ophthalmol Date: 2008-10
Authors: Richard W Cheng; Firdaus Yusof; Edmund Tsui; Monica Jong; James Duffin; John G Flanagan; Joseph A Fisher; Chris Hudson Journal: J Physiol Date: 2015-12-30 Impact factor: 5.182